SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-024533
Filing Date
2021-06-17
Accepted
2021-06-17 19:58:29
Documents
1
Period of Report
2021-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4030
  Complete submission text file 0000899243-21-024533.txt   5438
Mailing Address 285 SUMMER STREET UNIT 101 BOSTON MA 02210
Business Address 285 SUMMER STREET UNIT 101 BOSTON MA 02210 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BIODELIVERY SCIENCES INTERNATIONAL, INC. 4131 PARKLAKE AVE., SUITE 225 RALEIGH NC 27612
Business Address
Bailey Jeffrey Allen (Reporting) CIK: 0001500210 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38130 | Film No.: 211026641